SANIOR PARS AND MAIOR PARS IN CONTEMPORARY AREOPAGES: - PowerPoint PPT Presentation

1 / 29
About This Presentation
Title:

SANIOR PARS AND MAIOR PARS IN CONTEMPORARY AREOPAGES:

Description:

SANIOR PARS AND MAIOR PARS IN CONTEMPORARY AREOPAGES: Medicine evaluation committees in France and the United States Philippe Urfalino Collective Wisdom – PowerPoint PPT presentation

Number of Views:96
Avg rating:3.0/5.0
Slides: 30
Provided by: ceri160
Category:

less

Transcript and Presenter's Notes

Title: SANIOR PARS AND MAIOR PARS IN CONTEMPORARY AREOPAGES:


1
SANIOR PARS AND MAIOR PARS IN CONTEMPORARY
AREOPAGES
  • Medicine evaluation committees in France and the
    United States
  • Philippe Urfalino
  • Collective Wisdom
  • May 22-23 2008 Collège de France

2
How best to foster collective wisdom in
collectives of the wise?
  • The question of the aréopages, the committees of
    sages, of wise, of experts
  • Which have important decision to make for a
    social group

3
1. WHAT IS AN AREOPAGE ? (1)
  • 1. Aréopages are groups that deliberate to make
    decisions or advices that are applicable to a
    larger group.
  • 2. Members of an aréopage are appointed rather
    than elected. They are appointed first and
    foremost for their competence
  • 3. The collective work of the aréopage bears on
    to both the decision itself and argumentation to
    justify that decision.
  • 4. Individual aréopage members have to practice
    the discipline of arguing their position in
    accordance with certain validity requirements

4
1. WHAT IS AN AREOPAGE ? (2)
  • An Argumentative discipline
  • A. Justification reasons override motives
  • B. The justification has to be substantial one
    reason does not suffice, an entire line of
    reasoning is required.
  • C. The argumentation has to be appropriate this
    is specialized argumentation adapted to the
    matters of decision or advice.
  • D. Contexual validity arguments have to be
    adapted to the case at hand

5
2. The Problem of Such Committees (1)
  • As uninanimity is scarce a collective
    decision-making rule is needed
  • Voting is a good way to obtain a final point
  • But Voting has an uncertain relationship with the
    quality of the collective decision
  • the problem is
  • how to articulate number and reasons ?
  • How can votes be counted and weighed ?

6
2. The Problem of Such Committees (2)
  • The unstable solution of Western monastic orders
    for electing the head of the monastery
  • mixing sanior pars and maior pars
  • What was involved in this combination ?
  • The split of collective decision process in two
    parts
  • A hierarchical ordering principal

7
2. The Problem of Such Committees (3)
  •  WISE PART and MAJORITY PART 
  • the splitting of the decision-making process
  • On the one hand judgments and votes of
    participants
  • On the other hand evaluation of these judgments
    and of the result conducted by a part of the
    participants or by others
  • A hierarchical ordering principal
  • Without universally shared criteria, determining
    the wisest falls to an instance endowed with
    authority

8
2. The Problem of Such Committees (4)
  • Two different examples of contemporary means of
    finding a compromise between wise part and
    majority part
  • Two examples taken from the area of medicine
    evaluation
  • The French drug approval committee
  • The FDA and its advisory committees

9
3. Decision-making by exhaustion of objections
the French case
  • 3.1. Conditions for creating the French drug
    approval committee
  • 3.2. The rejection of vote
  • 3.3. Decision-making by apparent consensus
  • 3.4. Decision by exhaustion of objections
  • 3.5. Weakness of this decision-making rule

10
3.1. Conditions for creating the French drug
approval committee
  • Creating in 1978 for reducing between french
    medicine evaluation and those of other countries
  • The committee composed of a new generation of
    physicians and experts (outside the
    administration)
  • Between 1978 an 2000 approximately 30 members
    appointed for 3 years
  • No reassessing of the committee evaluation inside
    the administration or the agency (since 1993)
  • The committee makes the decision

11
3.2. The rejection of vote
  • From the beginning to now no vote but consensus
  • Why ? A fear and two ideas
  • Fear of contestation by pharmaceutical firms and
    medical milieu
  • Voting is not appropriate for reaching a decision
    with strong epistemic nature
  • Discussion on medicines can culminate in opinion
    convergence

12
3.3. Decision-making by apparent consensus
  • . What is decision-making by consensus if it is
    not a vote with unanimity rule ?
  • Decision-making by apparent consensus
  • - A specific sequence
  • - Two major characteristics

13
Decision-making by apparent consensusA specific
sequence
  • 1) a member presents to the assembly the nature
    of the problem requiring a decision
  • 2) the members discuss this presentation of the
    issue
  • 3) a member synthesizes the discussion and
    indicates which option seems to him to have
    emerged out of it
  • 4) at this point there are two possibilities
  • a) no one speaks out against the consensus
    proposal just presented, that proposal becomes
    the decision, or
  • b) at least one participant contests the
    synthesis proposal, in which case discussion
    starts up again until the same member or another
    one offers a new synthesis, which once again
    gives rise to situation a) or b)
  • 5) if all successive consensus proposals are
    contested, the decision-making process for that
    particular problem may be postponed until the
    next meeting.

14
Decision-making by apparent consensusTwo major
characteristics
  • No systematic expression or counting of opinions
  • Decision a proposal has not overt opposition
  • Apparent consensus is not unanimity
  • No explicitly rejection /visibly unanimoustly
    appoving
  • Apparent consensus some of who remain silence
    silent do not approve but no longer contest

15
3.4. Decision by exhaustion of objections (1)
  • The contesting of the proposal could have two
    different status
  • A rejection an unconditional veto right but the
    use of this veto right is conditional (ressources
    and negociation african palaver and
    international organizations)
  • An objection a conditional veto, the objection
    has to be accepted, deemed valid by others, but
    the use of objection is not conditionned by
    ressources or licit negociation

16
Decision by exhaustion of objections (2)
  • The silence of a member facing a proposal of a
    decision reflects 3 situations
  • He is convinced the proposal is the right one
  • He doesnt know and delegates his judgement
  • He is not convinced but he doesnt have a good
    argument

17
Decision by exhaustion of objections
(3)combining sanior pars with maior parts

Facing a proposal of decision A virtually silent majority An  objecting  minority
Values the expressed opinion In favor of the proposal as it stands Against the proposal as it stands
Expressions Explicit approval Or No expression Explicit disppproval
Mental states, reasons and preferences Convinced Indeterminated delegation of judgment Not convinced but having no argument for a valid objection - not convinced and having an objection that one deems validable
18
Decision by exhaustion of objections
(4)combining sanior pars with maior parts
  • The splitting of the collective decision process
  • The  objecting  minority judges the proposal
    and, by the way, the virtually silent majority
  • The hierarchical ordering principal
  • Prevalence of reasons on preference, of wisdom on
    number
  • The  objecting  minority win if the argument is
    deemed valid
  • Only two ways to express preference not
    contesting proposal or contesting it with an
    argument
  • The proposal become decision if it had exhausted
    objections, not because it would have won
    everyones vote
  • Unequal member influence is recognized legitimate

19
3.5. Two weak points of this decision-making rule
  • It tolerates delegation of judgement
  • (as silence means approbation of the proposal)
  • It presupposes a profound agreement on the
    evaluation approach
  • (if not such agreement, no convergence on the
    validity of objection but convergence on
    objections is less difficult to obtain than
    convergence on positives judgements Cf.
    Scanlon)

20
4. THE COLLECTIVE ADVISER
  • The Case of the FDAs Advisory Committees

21
4. THE COLLECTIVE ADVISER
  • 4.1. Conditions for Creating the Advisory
    Committees
  • 4.2. Voting Patterns The Strong Expert
    Convergence
  • 4.3. The Public Balloting of the Collective
    Adviser
  • 4.4. The Problematic Determination of Individual
    Will

22
4.1. Conditions for Creating the Advisory
Committees
  • Used systematically since the 1970s
  • 3 factors
  • Increasing complexity of technologies
  • New legislations
  • Growth of consumer activism and of critiques of
    agency decisions
  • AC do not concentrated all the expertise the FDA
    keeps the final decision
  • 18 AC for drugs with 11 menbers each

23
4.2. Voting Patterns The Strong Expert
Convergence
  • With the data of two studies of votes of several
    AC from 1998 to 2002 and from 2002 to 2007
  • Of the 70 instances of voting
  • 38 cases of unanimity
  • 10 (7) of scores below a 70 majority

24
4.3. The Public Balloting of the Collective
Adviser
  • A. The ambivalent status of voting
  • B. The moral force of majority rule

25
A. The Ambivalent Status of Voting (1)
  • The FDA wants voting on the questions that are
    the most directly linked to the decisions it must
    make
  • It recognizes that the voting can not be detached
    from discussions and comments
  • But it wants an Advisory committee to be a
    Collective Adviser

26
A. The Ambivalent Status of Voting (2)
  • Meanwhile, the voting does not need to reach a
    final point
  • A voting without decision-making rules (no
    majority rule)
  • The rare tie votes are not a problem
  • Frequent tie votes would ruin the
    orientation-giving function of the advisory
    committees on FDAs decisions
  • The concern for this orientation-giving function
    is demonstrated by the indirect presence of the
    majority rule

27
B. The Morale Force of Majority Rule
  • Advisory Committees do not have decision rule
    such as majority rule
  • But majority voting has a political and morale
    force
  • Controversies about the impact of conflicts of
    interest of AC members on their recommandations
    use the majority rule as criterion

28
4.4. The Problematic Determination of Individual
Will (1)
  • Some members have difficulties to answer Yes or
    no
  • - a few  abstain 
  • - some changes their vote
  • - a few wants to see what the others vote
    before voting (It is impossible since 2007)

29
4.4. The Problematic Determination of Individual
Will (2)
  • The links between reasons and votes
  • The vote is public, oral and with giving reasons
  • Sometimes the vote is embedded in the reasons
  • It then could loose is discrete nature
  •  yes, but   yes minimally 
  • The chairman has to unseal the vote from the
    discours  so it is yes 
Write a Comment
User Comments (0)
About PowerShow.com